Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Study of Raisins Versus Alternative Snacks in Patients With Type 2 Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial comparing raisins to alternative snacks in patients with Type 2 diabetes mellitus has completed and posted results.
-
CLINICAL_TRIALS research · 2014-04-23Clinical Trial Update: Effect of Managing Problematic Eating Behaviours With Dietary Management on Chronic Disease Self-management [NA]
A completed clinical trial evaluating whether dietary management of problematic eating behaviors improves chronic disease self-management in…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus [Phase 1]
This completed Phase 1 trial evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of JNJ-28431754 in patients with Typ…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: 30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 Weeks [Phase 3]
Phase 3 parallel-group study comparing linagliptin plus pioglitazone at 5+15, 5+30 and 5+45 mg once daily against corresponding monotherapie…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 Diabetes [Phase 3]
A long-term Phase 3 trial evaluating alogliptin added to rapid-acting insulin secretagogues in Type 2 diabetes has completed and results wer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes [Phase 4]
The INSPIRE Diabetes Study, a Phase 4 trial evaluating basal-bolus insulin as the primary treatment for Type 2 Diabetes, has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating autologous stem cell therapy combined with hyperbaric oxygen for Type 2 Diabetes Mellitus has completed,…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: A Community Pharmacy-based Program to Improve Management of Diabetes [NA]
The entry notes the completion of a community pharmacy-based program to improve management of Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)
This document reports the completed re-examination study of the sitagliptin/metformin combination JANUMET (0431A-182), with results posted i…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome [Phase 3]
Phase 3 cardiovascular outcomes study of alogliptin in adults with type 2 diabetes and acute coronary syndrome has completed and results hav…
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Acute Dose Response of Korean White Ginseng in Metabolic Syndrome or Type 2 Diabetes [Phase 1]
Phase 1 clinical trial evaluating the acute dose response of Korean White Ginseng in individuals with metabolic syndrome or type 2 diabetes …
-
FDA approval · 2014-04-11FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company. The action updates the product's label…
-
FDA approval · 2014-04-11FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating a multi-targeted cardiac risk intervention in type 2 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Orthogonal Polarisation Study in Young, Elderly and Type 2 Diabetics [NA]
Clinical trial update reports the completion of an orthogonal polarisation study conducted in young adults, elderly individuals, and patient…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes [NA]
Clinical trial examining how receiving genetic risk information for type 2 diabetes influences health behaviors and outcomes; completed.
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260) [Phase 3]
A Phase 3 study evaluating sitagliptin added to insulin for type 2 diabetes with inadequate glycemic control has completed, with results pos…
-
CLINICAL_TRIALS research · 2014-04-08Clinical Trial Update: Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial update evaluating linagliptin's effects on insulin sensitivity and pancreatic beta cell function in patients with Typ…
-
CLINICAL_TRIALS research · 2014-04-07Clinical Trial Update: Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia
A terminated clinical trial (NCT01599442) sponsored by GWT-TUD GmbH related to type 2 diabetes mellitus with diabetic foot syndrome and crit…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Impact of Cardiac Magnetic Resonance Imaging on Endothelial Function in Type 2 Diabetes [Phase 4]
Phase 4 trial evaluating the relationship between cardiac magnetic resonance imaging findings and endothelial function in people with Type 2…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Vitamin D and Adipose Tissue Inflammation [NA]
A completed clinical trial investigated the relationship between Vitamin D supplementation and adipose tissue inflammation in people with Vi…
-
FDA approval · 2014-04-03FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly, adding to the existing approval for this product. This action…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluating add-on vildagliptin to glimepiride versus placebo added to glimepiride in Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes [Phase 4]
Phase 4 trial evaluating postprandial hyperglycemia in adults with type 2 diabetes sponsored by Eli Lilly is completed, with results posted …
-
CLINICAL_TRIALS withdrawal · 2014-04-03Clinical Trial Update: Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes [Phase 2]
Phase 2 dose-finding trial of LIK066 in Type 2 diabetes was withdrawn, with the study comparing LIK066 to placebo or sitagliptin to assess H…